News

Filter

Current filters:

AstraZenecaevacetrapib

226 to 235 of 95973 results

Genentech files sBLA for Lucentis for diabetic retinopathy

09-08-2014

Genentech, the biotech subsidiary of Swiss pharma major Roche, has submitted a supplemental Biologics…

BiotechnologyGenentechLucentisOphthalmicsRegulationRocheUSA

FDA approves Janssen’s Invokamet for diabetes

09-08-2014

The US Food and Drug Administration has approved US health care giant Johnson & Johnson subsidiary Janssen…

DiabetesInvokametInvokanaJanssenJohnson & JohnsonPharmaceuticalRegulationUSA

Cancer Research UK and Astellas join forces on pancreatic cancer treatment

09-08-2014

Japanese drug major Astellas Pharma is joining forces with Cancer Research UK and its commercial arm,…

Astellas PharmaCancer Research TechnologyLicensingOncologyPharmaceuticalResearch

FDA fast tracks CTI BioPharma's pacritinib for myelofibrosis

FDA fast tracks CTI BioPharma's pacritinib for myelofibrosis

08-08-2014

US biotech firm CTI BioPharma (formerly called Cell Therapeutics) says that its pacritinib has been granted…

CTI BioPharmaOncologypacritinibPharmaceuticalRegulationUSA

MS market to reach $20 billion in 2023 boosted by five new therapies

MS market to reach $20 billion in 2023 boosted by five new therapies

08-08-2014

The forecast launch of five immunomodulatory therapies for relapsing forms of multiple sclerosis will…

CNS DiseasesEuropeImmunosuppressantsJapanMarkets & MarketingMSPharmaceuticalUSA

Australia pledges funding to find dementia breakthrough

Australia pledges funding to find dementia breakthrough

08-08-2014

The Australian Minister for Health, Peter Dutton, has announced the opening of a new round of dementia…

AustraliaCognitive disordersDementiaNeurologicalPharmaceuticalResearch

Clinigen backs white paper calling for recognition of early access schemes

Clinigen backs white paper calling for recognition of early access schemes

08-08-2014

UK-based Clinigen Group has published a new International Society for Pharmaceutical Engineering (ISPE)…

Clinigen GroupHealthcarePharmaceuticalRegulationUKUnited States

Added benefit of Novo Nordisk’s Tresiba not proven, says IQWiG

Added benefit of Novo Nordisk’s Tresiba not proven, says IQWiG

08-08-2014

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

DiabetesGerman Institute for Quality and EfficiencyGermanyNovo NordiskPharmaceuticalPricingRegulationTresiba

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

08-08-2014

In its early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

Biogen IdecBiotechnologyGermanyMSNeurologicalPricingRegulationTecfidera

226 to 235 of 95973 results

Back to top